Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT04904185
What this trial is testing

ImmPACT Expanded Multiple Antigen Specific Endogenously Derived T Cells (MASE-T) to Patients With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Inge Marie Svane 8
Not applicableStudy completedNCT03165409
What this trial is testing

Cost of Adverse Events Related to How Often Follow-Up Occurs Among Patients With Cancer That Has Spread

Who this might be right for
Melanoma
Bristol-Myers Squibb 1,828
Testing effectiveness (Phase 2)UnknownNCT03534635
What this trial is testing

Analysis of the Modulation of the Tumor Microenvironment by MK-3475 (Pembrolizumab) Using a Systems Biology Approach (PEMSYS)

Who this might be right for
Metastatic Melanoma Naive to Immune Therapy in Metastatic Setting
Centre Hospitalier Universitaire Vaudois 30
Not applicableLooking for participantsNCT06774989
What this trial is testing

Real-life Pharmacological Monitoring of Encorafenib-Binimetinib in the Treatment of Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Assistance Publique - Hôpitaux de Paris 66
Not applicableStudy completedNCT00974610
What this trial is testing

Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.

Who this might be right for
Breast CancerColorectal CancerLung Cancer+2 more
Cancer Trials Ireland 803
Large-scale testing (Phase 3)Study completedNCT02752074
What this trial is testing

Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)

Who this might be right for
Melanoma
Incyte Corporation 706
Early research (Phase 1)Study completedNCT00020540
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Not applicableStudy completedNCT03732560
What this trial is testing

A Comparison of Nivolumab-based Treatments in a Real-world PD-L1 Positive Metastatic Melanoma Population in the US

Who this might be right for
Melanoma
Bristol-Myers Squibb 600
Early research (Phase 1)Active Not RecruitingNCT04616248
What this trial is testing

In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaPrognostic Stage IV Breast Cancer AJCC v8+10 more
University of Southern California 14
Testing effectiveness (Phase 2)Ended earlyNCT04789668
What this trial is testing

Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Hematopoietic and Lymphoid Cell Neoplasm+11 more
M.D. Anderson Cancer Center 8
Not applicableStudy completedNCT01932489
What this trial is testing

The Jules Bordet Institute Molecular Profiling Program Feasibility Trial

Who this might be right for
Colorectal Cancer MetastaticMetastatic MelanomaMetastatic Non-Small Cell Lung Carcinoma
Jules Bordet Institute 35
Testing effectiveness (Phase 2)UnknownNCT00553618
What this trial is testing

Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients

Who this might be right for
Metastatic Melanoma
University of Louisville 160
Post-approval studies (Phase 4)Active Not RecruitingNCT02068196
What this trial is testing

A National Phase IV Study With Ipilimumab for Patients With Advanced Malignant Melanoma.

Who this might be right for
Malignant Melanoma
Oslo University Hospital 150
Testing effectiveness (Phase 2)Looking for participantsNCT07449754
What this trial is testing

Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma

Who this might be right for
Advanced or Metastatic Melanoma
Hanmi Pharmaceutical Company Limited 45
Testing effectiveness (Phase 2)WithdrawnNCT04242329
What this trial is testing

Surgery of Melanoma Metastases After Systemic Therapy

Who this might be right for
MelanomaMelanoma Stage IVMetastatic Melanoma+1 more
Vastra Gotaland Region
Early research (Phase 1)Study completedNCT03590054
What this trial is testing

Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Stage III Cutaneous MelanomaStage IV Cutaneous MelanomaLocally Advanced Melanoma+18 more
Rahul Aggarwal 35
Testing effectiveness (Phase 2)Ended earlyNCT04337931
What this trial is testing

Evaluate Sotigalimab (APX005M) in Subjects With Unresectable or Metastatic Melanoma

Who this might be right for
Unresectable MelanomaMetastatic MelanomaCancer+3 more
Apexigen America, Inc. 45
Testing effectiveness (Phase 2)Study completedNCT00623402
What this trial is testing

Combined Treatment of Sorafenib and Pegylated Interferon α2b in Stage IV Metastatic Melanoma

Who this might be right for
Melanoma
University Hospital Schleswig-Holstein 55
Early research (Phase 1)Study completedNCT00527761
What this trial is testing

Taxotere/Temodar/Cisplatin Study in Melanoma Patients

Who this might be right for
Metastatic Melanoma
M.D. Anderson Cancer Center 23
Next Page